Akebia Therapeutics, Inc. (AKBA)
0.7402
-0.02
(-3.19%)
USD |
NASDAQ |
Oct 29, 16:00
0.7455
+0.01
(+0.72%)
After-Hours: 20:00
Akebia Therapeutics Total Return Level : 0.7646 for Oct. 28, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 28, 2026 | 0.7646 |
| October 27, 2026 | 0.6604 |
| October 26, 2026 | 0.6438 |
| October 23, 2026 | 0.5669 |
| October 22, 2026 | 0.5622 |
| October 21, 2026 | 0.5853 |
| October 20, 2026 | 0.6181 |
| October 19, 2026 | 0.6801 |
| October 16, 2026 | 0.67 |
| October 15, 2026 | 0.6955 |
| October 14, 2026 | 0.702 |
| October 13, 2026 | 0.77 |
| October 12, 2026 | 0.7902 |
| October 09, 2026 | 0.8011 |
| October 08, 2026 | 0.8148 |
| October 07, 2026 | 0.8734 |
| October 06, 2026 | 0.8785 |
| October 05, 2026 | 0.9105 |
| October 02, 2026 | 0.865 |
| October 01, 2026 | 0.871 |
| September 30, 2026 | 0.92 |
| September 29, 2026 | 0.8861 |
| September 28, 2026 | 0.8931 |
| September 25, 2026 | 0.8962 |
| September 24, 2026 | 0.919 |
| Date | Value |
|---|---|
| September 23, 2026 | 0.9326 |
| September 22, 2026 | 0.98 |
| September 21, 2026 | 0.9385 |
| September 18, 2026 | 0.9157 |
| September 17, 2026 | 0.8955 |
| September 16, 2026 | 0.9178 |
| September 15, 2026 | 0.903 |
| September 14, 2026 | 0.9629 |
| September 11, 2026 | 0.9517 |
| September 10, 2026 | 0.9465 |
| September 09, 2026 | 0.9539 |
| September 08, 2026 | 1.03 |
| September 04, 2026 | 0.9747 |
| September 03, 2026 | 0.9833 |
| September 02, 2026 | 0.9803 |
| September 01, 2026 | 0.9447 |
| August 31, 2026 | 0.9188 |
| August 28, 2026 | 0.8786 |
| August 27, 2026 | 0.9398 |
| August 26, 2026 | 0.9065 |
| August 25, 2026 | 0.9584 |
| August 24, 2026 | 0.9006 |
| August 21, 2026 | 0.9066 |
| August 20, 2026 | 0.9194 |
| August 19, 2026 | 0.8854 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Emergent BioSolutions, Inc. | 7.09 |
| Exelixis, Inc. | 66.28 |
| ADMA Biologics, Inc. | 11.28 |
| Arcutis Biotherapeutics, Inc. | 31.45 |
| Relay Therapeutics, Inc. | 19.69 |